Clinical evidence for osteoarthritis as an inflammatory disease

被引:27
|
作者
Pincus T. [1 ]
机构
[1] Division of Rheumatology, Vanderbilt University Medical Center, 203 Oxford House, Box 5, Nashville, 37232-4500, TN
关键词
Acetaminophen; Etodolac; Misoprostol; Nabu; Nabumetone;
D O I
10.1007/s11926-001-0068-4
中图分类号
学科分类号
摘要
Osteoarthritis (OA) is not a simple consequence of “wear and tear” or aging—the presence of cytokines suggests a role for inflammation. OA is polyarticular in most patients, with metabolic and differential risk factors for prevalence and severity. Odds ratios for the prevalence of OA according to formal education levels are similar to those seen for dysregulatory diseases such as hypertension, diabetes, and rheumatoid arthritis. Clinical survey data indicate significant patient preference for nonsteroidal anti-inflammatory drugs (NSAIDs) compared with acetaminophen. A recent crossover clinical trial indicated significantly greater efficacy of the NSAID, diclofenac/misoprostol, versus acetaminophen for most patients with OA. © 2001, Current Science Inc.
引用
收藏
页码:524 / 534
页数:10
相关论文
共 50 条
  • [31] Inflammatory Bowel Disease, Clinical
    Morrison, G.
    Selby, W. S.
    Hetzel, D. J.
    Gibson, P. R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A311 - A311
  • [32] How strong is the contribution of inflammatory process to the clinical sign of osteoarthritis
    Kertia, N
    Savitri, KENY
    Danang
    Santoso, A
    Catur, E
    Broto, R
    Rahardjo, P
    Asdie, AH
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 479 - 479
  • [33] A review of the clinical evidence for exercise in osteoarthritis of the hip and knee
    Bennell, Kim L.
    Hinman, Rana S.
    JOURNAL OF SCIENCE AND MEDICINE IN SPORT, 2011, 14 (01) : 4 - 9
  • [34] Osteoarthritis and osteoporosis: Clinical and research evidence of inverse relationship
    Jan Dequeker
    Jeroen Aerssens
    Frank P. Luyten
    Aging Clinical and Experimental Research, 2003, 15 : 426 - 439
  • [35] Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms
    Mylène P. Jansen
    Simon C. Mastbergen
    Nature Reviews Rheumatology, 2022, 18 : 35 - 46
  • [36] Osteoarthritis and osteoporosis: Clinical and research evidence of inverse relationship
    Dequeker, J
    Aerssens, J
    Luyten, FP
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2003, 15 (05) : 426 - 439
  • [37] Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms
    Jansen, Mylene P.
    Mastbergen, Simon C.
    NATURE REVIEWS RHEUMATOLOGY, 2022, 18 (01) : 35 - 46
  • [38] Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence
    Rinonapoli, Giuseppe
    Coaccioli, Stefano
    Panella, Lorenzo
    JOURNAL OF PAIN RESEARCH, 2019, 12 : 1529 - 1536
  • [39] Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis
    Profit, Louise
    Chrisp, Paul
    CORE EVIDENCE, 2007, 2 (02) : 131 - 150
  • [40] Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease
    Steinhubl, Steven R.
    Badimon, Juan J.
    Bhatt, Deepak L.
    Herbert, Jean-Marc
    Luescher, Thomas F.
    VASCULAR MEDICINE, 2007, 12 (02) : 113 - 122